On May 21, James Hardie rose 7.22% in regular trading, trading at $19.96/share, with trading volume of $189 million.

On the news front, the company reported Q4 adjusted EPS of $0.30, beating the analyst consensus estimate of $0.29 by 3.45%. Q4 sales reached $1.404 billion, while adjusted net income came in at $172.6 million. More importantly, management issued upbeat FY2027 guidance, projecting full-year adjusted EBITDA of $1.45 billion to $1.5 billion and total net sales of $5.25 billion to $5.41 billion, with free cash flow expected to improve significantly. The company also targets 4% to 8% simulated adjusted EBITDA growth.

While management acknowledged uncertainty in the current operating environment, the combination of better-than-expected quarterly results and ambitious forward guidance significantly reinforced investor confidence in the company's long-term growth trajectory, driving the strong intraday gain.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)